Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Gadd45a contributes to p53 stabilization in response to DNA damage

Abstract

p53 is an important molecule in cellular response to DNA damage. After genotoxic stress, p53 protein stabilizes transiently and accumulates in the nucleus, where it functions as a transcription factor and upregulates multiple downstream-targeted genes, including p21Waf1/Cip1, Gadd45a and Bax. However, regulation of p53 stabilization is complex and may mainly involve post-translational modification of p53, such as phosphorylation and acetylation. Using mouse embryonic fibroblasts (MEFs) derived from Gadd45a knockouts, we found that disruption of Gadd45a greatly abolished p53 protein stabilization following UVB treatment. Phosphorylation of p53 at Ser-15 was substantially reduced in Gadd45a−/− MEFs. In addition, p53 induction by UVB was shown to be greatly abrogated in the presence of p38 kinase inhibitor, but not c-Jun N-terminal kinase (JNK) and extracellular-signal regulated kinase (ERK), suggesting that p38 protein kinase is involved in the regulation of p53 induction. Along with the findings presented above, inducible expression of Gadd45a enhanced p53 accumulation after cell exposure to UVB. Taken together, the current study demonstrates that Gadd45a, a conventional downstream gene of p53, may play a role as an upstream effector in p53 stabilization following DNA damage, and thus has defined a positive feedback signal in the activation of the p53 pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Ashcroft M, Kubbutat MH and Vousden KH . (1999). Mol. Cell. Biol., 19, 1751–1758.

  • Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y and Ziv Y . (1998). Science, 281, 1674–1677.

  • Bulavin DV, Kovalsky O, Hollander MC and Fornace Jr AJ . (2003). Mol. Cell. Biol., 23, 3859–3871.

  • Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E and Fornace Jr AJ . (1999). EMBO J., 18, 6845–6854.

  • Canman CE and Lim DS . (1998). Oncogene, 17, 3301–3308.

  • Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB and Siliciano JD . (1998). Science, 281, 1677–1679.

  • Chen CY, Oliner JD, Zhan Q, Fornace Jr AJ, Vogelstein B and Kastan MB . (1994). Proc. Natl. Acad. Sci. USA, 91, 2684–2688.

  • Dumaz N and Meek DW . (1999). EMBO J., 18, 7002–7010.

  • el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B . (1993). Cell, 75, 817–825.

  • Fornace Jr AJ, Alamo Jr I and Hollander MC . (1988). Proc. Natl. Acad. Sci. USA, 85, 8800–8804.

  • Fuchs SY, Adler V, Buschmann T, Wu X and Ronai Z . (1998a). Oncogene, 17, 2543–2547.

  • Fuchs SY, Adler V, Pincus MR and Ronai Z . (1998b). Proc. Natl. Acad. Sci. USA, 95, 10541–10546.

  • Haupt Y, Maya R, Kazaz A and Oren M . (1997). Nature, 387, 296–299.

  • Hildesheim J, Bulavin DV, Anver MR, Alvord WG, Hollander MC, Vardanian L and Fornace Jr AJ . (2002). Cancer Res., 62, 7305–7315.

  • Hollander MC, Alamo I, Jackman J, Wang MG, McBride OW and Fornace Jr AJ . (1993). J. Biol. Chem., 268, 24385–24393.

  • Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salguero PM, Morgan WF, Deng CX and Fornace Jr AJ . (1999). Nat. Genet., 23, 176–184.

  • Honda R, Tanaka H and Yasuda H . (1997). FEBS Lett., 420, 25–27.

  • Jin S, Antinore MJ, Lung FD, Dong X, Zhao H, Fan F, Colchagie AB, Blanck P, Roller PP, Fornace Jr AJ and Zhan Q . (2000). J. Biol. Chem., 275, 16602–16608.

  • Jin S, Tong T, Fan W, Fan F, Antinore MJ, Zhu X, Mazzacurati L, Li X, Petrik KL, Rajasekaran B, Wu M and Zhan Q . (2002). Oncogene, 21, 8696–8704.

  • Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW . (1991). Cancer Res., 51, 6304–6311.

  • Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace Jr AJ . (1992). Cell, 71, 587–597.

  • Kearsey JM, Coates PJ, Prescott AR, Warbrick E and Hall PA . (1995). Oncogene, 11, 1675–1683.

  • Lakin ND, Hann BC and Jackson SP . (1999). Oncogene, 18, 3989–3995.

  • Levine AJ . (1997). Cell, 88, 323–331.

  • Milne DM, Palmer RH and Meek DW . (1992). Nucleic Acids Res., 20, 5565–5570.

  • Miyashita T and Reed JC . (1995). Cell, 80, 293–299.

  • Oren M . (1999). J. Biol. Chem., 274, 36031–36034.

  • Sablina AA, Chumakov PM, Levine AJ and Kopnin BP . (2001). Oncogene, 20, 899–909.

  • Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW and Appella E . (1998). Genes Dev., 12, 2831–2841.

  • Shieh SY, Ikeda M, Taya Y and Prives C . (1997). Cell, 91, 325–334.

  • Shieh SY, Taya Y and Prives C . (1999). EMBO J., 18, 1815–1823.

  • Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E and Kastan MB . (1997). Genes Dev., 11, 3471–3481.

  • Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM and Fornace Jr AJ . (1994). Science, 266, 1376–1380.

  • Takekawa M and Saito H . (1998). Cell, 95, 521–530.

  • Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C and Abraham RT . (1999). Genes Dev., 13, 152–157.

  • Unger T, Juven-Gershon T, Moallem E, Berger M, Vogt Sionov R, Lozano G, Oren M and Haupt Y . (1999). EMBO J., 18, 1805–1814.

  • Vogelstein B and Kinzler KW . (1992). Cell, 70, 523–526.

  • Waldman T, Kinzler KW and Vogelstein B . (1995). Cancer Res., 55, 5187–5190.

  • Wang S and Shi X . (2001). Carcinogenesis, 22, 757–762.

  • Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace Jr. AJ and Harris CC . (1999). Proc. Natl. Acad. Sci. USA, 96, 3706–3711.

  • White E . (1996). Genes Dev., 10, 1–15.

  • Wu X, Bayle JH, Olson D and Levine AJ . (1993). Genes Dev., 7, 1126–1132.

  • Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC and Fornace Jr AJ . (1999). Oncogene, 18, 2892–2900.

  • Zhan Q, Bae I, Kastan MB and Fornace Jr AJ . (1994a). Cancer Res., 54, 2755–2760.

  • Zhan Q, Carrier F and Fornace Jr AJ . (1993). Mol. Cell. Biol., 13, 4242–4250.

  • Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM and Fornace Jr AJ . (1994b). Oncogene, 9, 3743–3751.

  • Zhan Q, Fan S, Smith ML, Bae I, Yu K, Alamo Jr I, O'Connor PM and Fornace Jr AJ . (1996). DNA Cell Biol., 15, 805–815.

  • Zhao H, Jin S, Antinore MJ, Lung FD, Fan F, Blanck P, Roller P, Fornace Jr AJ and Zhan Q . (2000). Exp. Cell Res., 258, 92–100.

Download references

Acknowledgements

We are grateful to Albert J Fornace and M Christine Hollander for providing us with ER1 and ER-11 cell lines, as well as constructive discussion during the project. This work is supported in part by National Institutes of Health Grant R01 CA-83874, DOD Grant DAMD17-00-1-0414, National Key Basic Research Program (2002 CB513101) and National Natural Science Foundation of China Grant (30225018).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qimin Zhan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jin, S., Mazzacurati, L., Zhu, X. et al. Gadd45a contributes to p53 stabilization in response to DNA damage. Oncogene 22, 8536–8540 (2003). https://doi.org/10.1038/sj.onc.1206907

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206907

Keywords

This article is cited by

Search

Quick links